Edward Y. Lau

Sydney, NSW, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Antipsychotic Drug Interactions and Short-Term Mortality Risk in People With Dementia: A National Cohort Study.

Antipsychotic Drug Interactions and Short-Term Mortality Risk in People With Dementia: A National Cohort Study.

Journal: Clinical pharmacology and therapeutics
Published: March 23, 2026

Leveraging Artificial Intelligence for Immune Checkpoint Inhibitor Safety: A Scoping Review of Current Applications.

Leveraging Artificial Intelligence for Immune Checkpoint Inhibitor Safety: A Scoping Review of Current Applications.

Journal: JCO clinical cancer informatics
Published: March 09, 2026

Influence of patient characteristics on efficacy and safety of anti-amyloid monoclonal antibodies in Alzheimer's disease: A systematic review and meta-analysis.

Influence of patient characteristics on efficacy and safety of anti-amyloid monoclonal antibodies in Alzheimer's disease: A systematic review and meta-analysis.

Journal: Ageing research reviews
Published: October 06, 2025

Multiple Adverse Outcomes Associated with Risperidone in People with Dementia: An Individual Participant Data Meta-Analysis.

Multiple Adverse Outcomes Associated with Risperidone in People with Dementia: An Individual Participant Data Meta-Analysis.

Journal: CNS drugs
Published: September 30, 2025

Developing a Novel Digital Tool for Personalised Antipsychotic Prescribing in People Living With Dementia: The Views of Australian Clinicians.

Developing a Novel Digital Tool for Personalised Antipsychotic Prescribing in People Living With Dementia: The Views of Australian Clinicians.

Journal: Dementia (London, England)
Published: August 05, 2025

Prevalence and Risk Factors for Psychotropic Medication Use in Older Adults in Australia: A Nationwide Data Linkage Study.

Prevalence and Risk Factors for Psychotropic Medication Use in Older Adults in Australia: A Nationwide Data Linkage Study.

Journal: Drugs & aging
Published: June 02, 2025

High-Risk Prescribing in Older People With and Without Dementia in Australia: A Nationwide Cross-Sectional Study.

High-Risk Prescribing in Older People With and Without Dementia in Australia: A Nationwide Cross-Sectional Study.

Journal: Journal of the American Medical Directors Association
Published: May 17, 2025

Treatment modifiers and predictors of risperidone response in dementia: An individual participant data meta-analysis of six randomized controlled trials.

Treatment modifiers and predictors of risperidone response in dementia: An individual participant data meta-analysis of six randomized controlled trials.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: April 29, 2025

Potentially High-Risk Antipsychotic Use in People With Dementia: A National Data Linkage Study.

Potentially High-Risk Antipsychotic Use in People With Dementia: A National Data Linkage Study.

Journal: Journal of the American Medical Directors Association
Published: April 08, 2025

Predictors and Moderators of Hospitalisation and Mortality in People with Dementia Using Antipsychotics: Systematic Review.

Predictors and Moderators of Hospitalisation and Mortality in People with Dementia Using Antipsychotics: Systematic Review.

Journal: Drugs & aging
Published: March 17, 2025

Antidementia and Psychotropic Drug Use in Older People with Dementia in Australia: A National Data Linkage Study.

Antidementia and Psychotropic Drug Use in Older People with Dementia in Australia: A National Data Linkage Study.

Journal: Journal of the American Medical Directors Association
Published: April 23, 2024

Prevalence of and Risk Factors for Drug-Related Readmissions in Older Adults: A Systematic Review and Meta-Analysis.

Prevalence of and Risk Factors for Drug-Related Readmissions in Older Adults: A Systematic Review and Meta-Analysis.

Journal: Drugs & aging
Published: October 04, 2023
Showing 1-12 of 14

Last Updated: 09/26/2026